Clinical Trial Update: Immunotherapy in Lymphoma

View source ↗

Summary

An ongoing immunotherapy trial for relapsed or refractory B-cell lymphomas is currently recruiting. The study targets high-grade B-cell lymphoma, diffuse large …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma

Snippet

Sponsor: Sung-Soo Park | Conditions: Relapsed/refractory High Grade B Cell Lymphoma, High Grade B-cell Lymphoma | Status: RECRUITING